Comparative Analysis of Biomarkers in CAD: Evaluating Homocysteine, Lipid HS-CRP, Apo A, and ADMA

Sonu Kumar Singh1, Roshan Kumar Jha1, Ranjit S Ambad1

  • 1Department of Biochemistry, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Sawangi (M), Wardha, Maharashtra, India.

Insights

Coronary artery disease (CAD) risk is predicted by LDL, homocysteine, and TC/HDL ratio. These biomarkers, along with traditional factors, offer effective CAD risk assessment, as shown in a case-control study.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Epidemiology

Background:

  • Coronary artery disease (CAD) is a major global health concern due to atherosclerosis.
  • Identifying reliable biomarkers for CAD risk is crucial for early intervention.

Purpose of the Study:

  • To compare traditional and emerging biomarkers in CAD patients versus controls.
  • To analyze risk factors, biomarkers, and clinical traits associated with CAD.

Main Methods:

  • A case-control study involving 200 participants (100 CAD cases, 100 controls).
  • Analysis of demographic variables, traditional risk factors (hypertension, smoking, alcohol), and biochemical markers including lipid profiles, homocysteine, HS-CRP, ADMA, and apolipoproteins (Apo A1, Apo B).

Main Results:

  • Low-density lipoprotein (LDL), homocysteine, and total cholesterol/high-density lipoprotein (TC/HDL) ratio were identified as significant predictors of CAD.
  • The regression model demonstrated high explanatory power (R² = 97.2%), validating these indicators.

Conclusions:

  • Traditional and emerging risk factors significantly contribute to CAD progression.
  • LDL, homocysteine, and TC/HDL ratio are validated as effective indicators for CAD risk assessment.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
68
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
119
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
140